News Headlines Article

Medicare drug price arbitration gains steam in the House
Modern Healthcare

House Ways and Means Committee Chair Richard Neal (D-Mass.) will broach the idea of using arbitration to give HHS leverage with drug manufacturers over prices in a hearing next Tuesday.

The committee plans to convene a hearing to discuss a bipartisan set of bills aimed at drug price transparency, the chairman said. But he said that he and the panel’s Ranking Member Kevin Brady (R-Texas) have discussed arbitration “in a general way” in their regular talks. He described those talks as “fluid,” but confirmed that a policy like arbitration is possible.